Biomerica Inc financial data

Symbol
BMRA on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
Location
17571 Von Karman Avenue, Irvine, CA
State of incorporation
DE
Fiscal year end
May 31
Latest financial report
10-Q - Q1 2025 - Apr 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 334 % -42.3%
Quick Ratio 98.5 % -6.47%
Debt-to-equity 40.7 % +58.9%
Return On Equity -85.9 % -34.2%
Return On Assets -61.1 % -19.8%
Operating Margin -89.8 % +27.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 20.4M shares +21.1%
Common Stock, Shares, Outstanding 20.4M shares +21.1%
Entity Public Float 14.5M USD -66%
Common Stock, Value, Issued 1.63M USD +21%
Weighted Average Number of Shares Outstanding, Basic 19.2M shares +14.1%
Weighted Average Number of Shares Outstanding, Diluted 19.2M shares +14.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 5.68M USD +5.07%
Revenue from Contract with Customer, Excluding Assessed Tax 5.68M USD +5.07%
Cost of Revenue 4.91M USD +2.57%
Research and Development Expense 1.04M USD -35.2%
Operating Income (Loss) -5.1M USD +23.6%
Nonoperating Income (Expense) 252K USD -32.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -4.85M USD +23.1%
Income Tax Expense (Benefit) 4K USD -91.7%
Net Income (Loss) Attributable to Parent -4.85M USD +23.6%
Earnings Per Share, Basic -0.29 USD/shares +21.6%
Earnings Per Share, Diluted -0.29 USD/shares +21.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.06M USD -42.5%
Accounts Receivable, after Allowance for Credit Loss, Current 1.27M USD +12.2%
Inventory, Net 1.66M USD -22.3%
Assets, Current 6.2M USD -29.9%
Property, Plant and Equipment, Net 151K USD -22.2%
Operating Lease, Right-of-Use Asset 509K USD -37.7%
Intangible Assets, Net (Excluding Goodwill) 234K USD +8.33%
Other Assets, Noncurrent 113K USD +8.65%
Assets 7.38M USD -28.7%
Accounts Payable, Current 288K USD -16.3%
Employee-related Liabilities, Current 612K USD -12.8%
Accrued Liabilities, Current 850K USD +55.1%
Liabilities, Current 1.65M USD -17.2%
Operating Lease, Liability, Noncurrent 193K USD -64.5%
Liabilities 1.84M USD -27.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -113K USD -10.8%
Retained Earnings (Accumulated Deficit) -51.6M USD -10.4%
Stockholders' Equity Attributable to Parent 5.53M USD -29.1%
Liabilities and Equity 7.38M USD -28.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.34M USD +19.7%
Net Cash Provided by (Used in) Investing Activities -63K USD -85.3%
Common Stock, Shares Authorized 25M shares 0%
Common Stock, Shares, Issued 20.4M shares +21.1%
Common Stock, Par or Stated Value Per Share 0.08 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.35M USD +22%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.35M USD -67.1%
Deferred Tax Assets, Valuation Allowance 10.4M USD +16%
Deferred Tax Assets, Gross 10.4M USD +16%
Operating Lease, Liability 543K USD -37%
Payments to Acquire Property, Plant, and Equipment 21K USD -38.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -4.86M USD +23.3%
Lessee, Operating Lease, Liability, to be Paid 569K USD -39%
Operating Lease, Liability, Current 350K USD +9.72%
Lessee, Operating Lease, Liability, to be Paid, Year Two 7K USD -98.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 195K USD -47.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 26K USD -63.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 101K USD -73.1%
Deferred Tax Assets, Operating Loss Carryforwards 6.66M USD +14.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 4.43M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 101K USD -73.7%
Operating Lease, Payments 90K USD +3.45%
Additional Paid in Capital 55.6M USD +4.32%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 18K USD +12.5%
Depreciation, Depletion and Amortization 76K USD -77.6%
Deferred Tax Assets, Net of Valuation Allowance 8.09M USD
Share-based Payment Arrangement, Expense 528K USD -34.9%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares